Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
20.90    -0.10 (-0.48%)
Bid:
20.90
Ask:
21.90
Spread: 1.00 (4.785%)
Market Cap: €116.00b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

BBVA Dividend option

11 Apr 2012 18:22

RNS Number : 1696B
Banco Bilbao Vizcaya Argentaria SA
11 April 2012
 

 

 

Banco Bilbao Vizcaya Argentaria, S.A.(BBVA), in compliance with the Securities Market legislation, hereby communicates the following:

 

 

 

RELEVANT EVENT

In connection with the relevant event of March 28, 2012 (Filing No. 160866), BBVA hereby submits, for purposes of articles 26.1.e) and 41.1.d) of Royal Decree 1310/2005 of November 4, this supplementary document to the Information Document relating to the free-of-charge capital increase by which a system of flexible shareholder remuneration called "Dividend Option" is to be instrumented.

 

Madrid, April 11, 2012

 

supplementary document to the Information Document

 

CAPITAL INCREASE CHARGED TO VOLUNTARY RESERVES

 

BANCO BILBAO VIZCAYA ARGENTARIA, S.A.

 

 

April 11, 2012

 

  

THIS DOCUMENT HAS BEEN PREPARED IN ACCORDANCE WITH ARTICLES 26.1.E) AND 41.1.D) OF ROYAL DECREE 1310/2005 OF NOVEMBER 4.

 

Disclaimer: The English version is a free translation of the original in Spanish for information purposes only. In the event of discrepancy, the Spanish original will prevail

1. INTRODUCTION

This document (the "Supplementary Document") has been issued to supplement the information provided in the information document relating to the capital increase charged to voluntary reserves approved by the ordinary general shareholders' meeting of Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA" or the "Bank") held on March 16, 2012, under item 4.1 of the fourth point of its agenda (the "Capital Increase"), which was published by means of a relevant event on March 28, 2012, with filing number 160866 (the "Information Document"). Capitalized terms used but not defined herein have the meanings assigned to them in the Information Document.

This Supplementary Document sets forth below the information relating to the Capital Increase which was outstanding at the date of publication of the Information Document and, in particular, the number of shares to be issued (with the possibility of incomplete subscription being expressly provided for), the number of free allotment rights necessary to receive one new share ("NAR") and the price at which BBVA has undertaken to acquire free allotment rights from shareholders, in the terms set forth in the Information Document.

This Supplementary Document and the Information Document have been issued in accordance with articles 26.1.e) and 41.1.d) of Royal Decree 1310/2005, of November 4, which provide that the preparation and publication of a prospectus related to the issuance and admission to listing of the shares issued as a consequence of the execution of the Capital Increase will not be necessary "provided that a document is made available containing information on the number and nature of the shares and the reasons for and details of the offer". This Supplementary Document together with the Information Document constitute such document. This Supplementary Document and the Information Document are available on the CNMV's website (www.cnmv.es) and the Bank's website (www.bbva.com).

2. SUPPLEMENTARY INFORMATION TO THE INFORMATION DOCUMENT

The Executive Committee of BBVA, in its meeting held on April 11, 2012, has agreed to implement the Capital Increase in accordance with the terms approved by the ordinary general shareholders' meeting of BBVA held on March 16, 2012, under item 4.1 of the fourth point of its agenda, and by the Board of Directors of BBVA, in its meeting held on March 28, 2012. In accordance with the formulas approved by these bodies, the Executive Committee has approved the following parameters concerning the Capital Increase:

(i) The number of new shares to be issued as a consequence of the execution of the Capital Increase ("New Shares") will be 107,682,603 New Shares. Accordingly, the aggregate nominal value of the Capital Increase will be €52,764,475.47, which is the product of multiplying the number of New Shares 107,682,603 by the nominal value of €0.49 per New Share.

The number of New Shares to be issued is the result of applying the formulas provided for in the applicable resolution adopted by the ordinary general shareholders' meeting of BBVA held on March 16, 2012, under item 4.1 of the fourth point of its agenda, and by the Board of Directors of BBVA, in its meeting held on March 28, 2012, considering that the number of old shares outstanding is 5,061,082,3781 ("NOS"), that the reference market value is €615,000,000 ("RMV") and that the reference price is €5.677 ("reference price" or "RP").2 On this basis:

(a) The number of rights to be assigned ("rights to be assigned" or "NAR") is 47, in accordance with the formula in the shareholders' and board's resolutions (rounded up to the nearest whole number):

NAR = RP x NOS / RMV

which, as applied, results in:

NAR = €5.677 x 5,061,082,378 / 615,000,000 = 47

(b) The number of New Shares to be issued is 107,682,603 New Shares, in accordance with the formula in the shareholders' and board's resolutions (rounded down to the nearest whole number):

New Shares = NOS / NAR

which, as applied, results in:

New Shares = 5,061,082,378 / 47 = 107,682,603

Notwithstanding this, the number of New Shares actually issued and, as a result, the nominal value of the Capital Increase may be less than the foregoing depending on the number of rights acquired by the Bank pursuant to its undertaking to acquire the free allotment rights for a fixed price. BBVA will waive the free allotment rights acquired pursuant to such undertaking. As a result, only those shares corresponding to the free allotment rights which have not been acquired by BBVA pursuant to its undertaking will be issued.

The New Shares will be issued at their nominal value of forty-nine euro cents (€0.49) per New Share, without issuance premium.

1 This amount reflects the voluntary conversion into shares, at the option of the holders, of BBVA’s mandatory convertible subordinated bonds issued in December 2011, after which the number of old shares outstanding is 5,061,082,378.
2 The Reference Price corresponds to the arithmetic mean of the weighted average prices of BBVA’s shares on the Spanish Stock Exchanges (Mercado Continuo) over the five trading sessions immediately prior to April 11, 2012, the date that BBVA’s Executive Committee resolved to effect the Capital Increase, rounded to the nearest thousandth of a euro and, in the case of a half of a thousandth of a euro, the immediately higher thousandth of a euro. 

(ii) The number of rights necessary to receive one New Share is 47.

BBVA shareholders who appear as such in the book-entry registries of Sociedad de Gestión de los Sistemas de Registro, Compensación y Liquidación de Valores, S.A. ("Iberclear") at 23:59 Madrid time on the day of publication of the announcement of the Capital Increase in the Official Bulletin of the Commercial Registry ("Boletín Oficial del Registro Mercantil") (envisaged for April 13, 2012) will receive a free allotment right for each BBVA share held. Consequently, such shareholders will have a right to receive one New Share for each 47 shares held by them on such date.

To ensure that all free allotment rights are effectively exercisable and that the number of New Shares to be issued is a whole number, BBVA has renounced 37 rights corresponding to 37 shares held as treasury shares.

(iii) The fixed purchase price of each freely allotted right assumed by BBVA is €0.118 per right, in accordance with the formula approved by the ordinary general shareholders' meeting of BBVA held on March 16, 2012, under item 4.1 of the fourth point of its agenda, and by the Board of Directors of BBVA, in its meeting held on March 28, 2012 (rounded to the nearest thousandth of a euro and, in the case of a half of a thousandth of a euro, the immediately higher thousandth of a euro):

Purchase price = RP / (NAR +1)

which, as applied, results in:

Purchase price = 5.677 / (47 + 1) = €0.118

Accordingly, shareholders who wish to receive a dividend in cash can sell their rights to BBVA at a gross fixed price of €0.118 per right.

As indicated in the Information Document, this option is granted exclusively to the shareholders of BBVA who have such condition at the time the free allotment rights are allocated and only in connection with the free allotment rights which are originally allocated to them at such time; accordingly, this option will not be available in respect of any free allotment right acquired through a market purchase.

BBVA's undertaking to acquire rights at this fixed price will be in effect from the first trading day of the rights, which is expected to take place on April 16, 2012 through April 25, 2012, both inclusive.3

3 The options, terms and procedures indicated in this information document may not be the same in respect of BBVA shares listed outside Spain, including in the form of BBVA ADSs.

* * *

Banco Bilbao Vizcaya Argentaria, S.A.

P.p.

Erik Schotkamp

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIBMRTMBBBBTT
Date   Source Headline
12th Apr 20179:24 amRNSPre Stabilisation Notice
5th Apr 20174:51 pmRNSFinal Terms GMTN Programme
3rd Apr 20179:31 amRNSPre Stabilisation Notice
30th Mar 20177:00 amRNSDividend Option Information April 2017
22nd Mar 20178:12 amRNSBBVA completes the acquisition of 9.95% of Garanti
20th Mar 20177:00 amRNSBasel Accord Pillar III
17th Mar 20173:05 pmRNSDividend Option April 2017
17th Mar 20172:58 pmRNSResolutions adopted by the General Meeting
16th Mar 20171:36 pmRNSFinal Terms GMTN Programme
14th Mar 20173:55 pmRNSFinal Terms GMTN Programme
8th Mar 201711:36 amRNSDBRS has assigned BBVA an Issuer Rating
24th Feb 20173:49 pmRNSSupplemental to the Offering Circular GMTN
24th Feb 201710:29 amRNSFinal Terms GMTN Programme
22nd Feb 20177:00 amRNSAcquisition agreement 9,95% of Garanti
14th Feb 20174:07 pmRNSSupplemental to the Offering Circular
14th Feb 20171:26 pmRNSBBVA Annual Report 2016 (spanish version)
14th Feb 20171:22 pmRNSBBVA Annual Report 2016
14th Feb 20179:06 amRNSNotice of AGM
10th Feb 20177:00 amRNSAnnual General Meeting 2017 Call
8th Feb 20173:04 pmRNSFinal Terms - Global Medium Term Note Programme
6th Feb 201710:15 amRNSPost-Stab Notice BBVA EUR 5yr Senior
3rd Feb 20173:34 pmRNSStabilisation Notice
2nd Feb 20178:37 amRNSStabilisation Notice - BBVA T2
1st Feb 20174:36 pmRNSSupplemental to the Offering Circular
1st Feb 20177:16 amRNS4Q16 Results Presentation
1st Feb 20177:10 amRNS4Q16 Results Report
1st Feb 20177:05 amRNSPress Release 4Q16 Results
1st Feb 20177:00 amRNSShareholder Remuneration Policy
27th Jan 20177:48 amRNS4Q16 Results presentation announcement
23rd Jan 20177:46 amRNSRDL Mortgage Floor Clauses
11th Jan 201712:09 pmRNSFinal Terms Global Medium Term Note Programme
5th Jan 201710:10 amRNSPre Stabilisation Notice BBVA EUR 5yr Senior
4th Jan 20173:21 pmRNSPublication of Approved ECP Supplement
28th Dec 20167:00 amRNSSupplemental to the Offering Circular
22nd Dec 20163:51 pmRNSPublication of approved ECP Listing Particulars
22nd Dec 20167:00 amRNSDividend January 2017
21st Dec 20162:23 pmRNSMortgage Floor Clauses
19th Dec 201610:43 amRNSSupplemental to the Offering Circular
1st Dec 20167:48 amRNSSREP capital requirement
25th Nov 20161:24 pmRNSOffering Circular
23rd Nov 20165:44 pmRNSBBVA SA Annual Report 2015
23rd Nov 20165:28 pmRNSBBVA SA Annual Report 2014
23rd Nov 20165:19 pmRNSForm 6-K
23rd Nov 20165:04 pmRNSForm 20-F 2015
7th Nov 20163:32 pmRNSSupplemental to the Offering Circular
4th Nov 201612:18 pmRNSDividend Option
27th Oct 20167:00 amRNS3rd Quarter Results Presentation
27th Oct 20167:00 amRNS3rd Quarter Results Information
27th Oct 20167:00 amRNS3rd Quarter Results
24th Oct 20165:02 pmRNSHR 3Q16 Results presentation announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.